课题基金 / 基金详情

Analysis of expressional changes of liver enriched transcription factors during occurrence and development of hepatocellular carcinoma, its application to pathological diagnosis and gene therapy

Analysis of expressional changes of liver enriched transcription factors during occurrence and development of hepatocellular carcinoma, its application to pathological diagnosis and gene therapy
肝细胞癌发生发展过程中肝脏富集转录因子表达变化分析及其在病理诊断和基因治疗中的应用
批准号:
10470049
负责人:
YOSHITAKE Hayashi
金额:
$6.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
几个肝脏富集的转录因子被确定,其表达的调控已经众所周知。我们发现,在从高分化肝细胞癌(HCC)向低分化HCC的去分化过程中,HNF-1 α表达下降,而HNF-1β保持不变。我们还表征了未分化HCC细胞系,称为ETK-1,其具有像肝干细胞一样的双向分化能力,既可分化为肝细胞,称为MEK,也可分化为胆管上皮细胞,ETK-1细胞既不表达HNF-1α,也不表达HNF-4。MEK细胞表达HNF-1α和HNF-4。NEC仅表达HNF-4,不表达HNF-1α。ETK-1和NEC不表达转甲状腺素蛋白、白蛋白、甲胎蛋白等肝特异性基因,而MEK表达所有肝特异性基因。本研究主要探讨NEC表达HNF-4但不表达肝特异性基因或HNF-1α的机制。荧光 关于我们 在NEC细胞中,HNF-4定位于细胞质而非细胞核。HNF-4不能从细胞质转移到细胞核,这可能导致其作为转录调节因子的功能缺陷。我们还分析了在HCC去分化过程中参与肝富集转录调控的信号转导分子,对手术切除的HCC组织进行免疫组化和western-和north-blot分析表明,SAP-1的过度表达,SAP-1在高分化肝癌中的表达,在肝癌去分化过程中表达下降。转基因诱导SAP-1在低分化肝癌细胞系中过表达,引起肝癌再分化,并抑制细胞增殖和侵袭。SAP-1可能通过肝细胞分化参与HCC的演变和转移。少
英文摘要
Several liver enriched transcription factors were identified and the regulation of their expressions has been well known. We showed that HNF-1a expression decreased, although HNF-1β remained unchanged, during dedifferentiation from well differentiated hepatocellular carcinoma (HCC) to poorly differentiated HCC.We also characterized an undifferentiated HCC cell-line, referred to as ETK-1, which has the potency of bilateral differentiation, like liver stem cell, into both hepatocyte, referred to as MEK, and biliary epithelial cell, referred to as NEC.ETK-1 cell expressed neither HNF-1α nor HNF-4. MEK cell showed expression of both HNF-1α and HNF-4. NEC expressed only HNF-4, but not HNF-1α. ETK-1 and NEC had no expression of liver specific genes, such as transthyretin and albumin, AFP and so on, although MEK expressed all sets of liver specific genes. Our study focused on the mechanism how NEC has no expression of liver specific genes or HNF-1α in spite of its expression of HNF-4. Fluores … More cent microscopic observations of NEC cell demonstrated that the HNF-4 located in the cytoplasm, not in the nucleus. The lack of transference of HNF-4 from cytoplasm into nucleus seemed to induce its functional defect as a transcription regulator. Such abnormal distribution of nuclear transcription factors might be an important process in dedifferentiation of HCC.We also analysed the signal transduction molecules inplicated in liver enriched transcription regulation during dedifferentiation of HCC.Immunohistochemical and western- and northern-blot analysis of surgically hepatectomized HCC tissues showed that overexpression of SAP-1, a human transmembrane-type protein tyrosine phosphatase in well differentiated HCC and its expression decreased during dedifferentiation of HCC.Induction of overexpression of SAP-1 in poorly differentiated HCC cell-line by transgene caused redifferentiation of HCC, and suppressed cellular proliferation and invasion. SAP-1 may be a molecule implicated in evolution and metastasis of HCC through hepatocytic differentiation. Less
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
Zhou L et al: "Expression of Urokinase-Type Plasminogen Activator, Urokinase-Type Plasminogen Activator Inhibitor-1 and-2 in Hepatocellular Carcinoma"Pathology International. 50. 392-397 (2000)
Zhou L等人:“尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂抑制剂-1和-2在肝细胞癌中的表达”国际病理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
林 祥剛: "病理組織形態に反映する転写制御因子-肝細胞特異核蛋白発現の肝癌診断、治療への応用" 病理と臨床. (印刷中).
Yoshitake Hayashi:“病理组织形态学中反映的转录控制因素 - 肝细胞特异性核蛋白表达在肝癌诊断和治疗中的应用”病理学和临床实践(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kentaro Kawasaki: "Expression of urokinase plasminogen activator receptor(uPAR)and plasminogen activator inhibitor-1(PAI-1)in the gastric cancer" J Gastroenterol Hepatol. 13. 892-896 (1998)
Kentaro Kawasaki:“尿激酶纤溶酶原激活剂受体(uPAR)和纤溶酶原激活剂抑制剂-1(PAI-1)在胃癌中的表达”J Gastroenterol Hepatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoshi Suzuki: "Expression of receptor for urokinase plasminogen activator in colorectal adnomas and carcinomas" GUT. 43. 798-805 (1998)
Satoshi Suzuki:“尿激酶纤溶酶原激活剂受体在结直肠腺瘤和癌中的表达”GUT。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    国内基金
    海外基金
    矢志方调控HNF-4α改善高尿酸血症脂代谢紊乱的机制研究
    • 批准号:
      JCZRLH202600857
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    HNF-4α联合HNF-3γ诱导脂肪间充质干细胞向肝细胞分化研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2019
    • 负责人:
      史政荣
    • 依托单位:
    黄连素通过调控肝脏HNF-4α/miR122通路纠正糖尿病糖脂代谢紊乱机制研究
    • 批准号:
      81200598
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2012
    • 负责人:
      张明
    • 依托单位:
    miRNA在HNF-4α诱导肝癌干细胞分化过程中的表达和功能研究